Q2 EPS Forecast for Cogent Biosciences Increased by Analyst
Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Investment analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for Cogent Biosciences in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst A. Berens now expects that the technology company will earn ($0.63) per share for the quarter, up from their […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Free Report) – Investment analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for Cogent Biosciences in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst A. Berens now expects that the technology company will earn ($0.63) per share for the quarter, up from their […]
